This announcement is a separate document:
北京君合（成都）律师事务所关于海创药业股份有限公司2023年第二次临时股东大会的法律意见书
Legal Opinion of Beijing Junhe (Chengdu) Law Firm on the 2023 Second Extraordinary General Meeting of Shareholders of Haichuang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.